Associated Papers
Chromogranin B: A versatile neuroendocrine protein regulating physiological and metabolic functions.
Mukherjee C et al.
Neuropeptides, 2025
Comprehensive Analysis of Human Colorectal Cancers Harboring Polymerase Epsilon Mutations.
Gibson LM et al.
International Journal of Molecular Sciences, 2025
A systematic review and functional in-silico analysis of genes and variants associated with amyotrophic lateral sclerosis.
Arreola-Aldape CA et al.
Frontiers in Neuroscience, 2025
Genetic Modifiers of ALS: The Impact of Chromogranin B P413L in a Bulgarian ALS Cohort.
Tourtourikov I et al.
Genes, 2024
Brain-body mechanisms contribute to sexual dimorphism in amyotrophic lateral sclerosis.
Jacob SM et al.
Nature Reviews. Neurology, 2024
Indicators of HSV1 Infection, ECM-Receptor Interaction, and Chromatin Modulation in a Nuclear Family with Schizophrenia.
Huang YC et al.
Journal of Personalized Medicine, 2023
High-Throughput Genetic Testing in ALS: The Challenging Path of Variant Classification Considering the ACMG Guidelines.
Lattante S et al.
Genes, 2020
Genetics and Sex in the Pathogenesis of Amyotrophic Lateral Sclerosis (ALS): Is There a Link?
Trojsi F et al.
International Journal of Molecular Sciences, 2020
New molecular diagnostic trends and biomarkers for amyotrophic lateral sclerosis.
Pampalakis G et al.
Human Mutation, 2019
Protein-protein interactions reveal key canonical pathways, upstream regulators, interactome domains, and novel targets in ALS.
Dervishi I et al.
Scientific Reports, 2018
Secretory granule protein chromogranin B (CHGB) forms an anion channel in membranes.
Yadav GP et al.
Life Science Alliance, 2018
Genetics of Amyotrophic Lateral Sclerosis.
Ghasemi M et al.
Cold Spring Harbor Perspectives in Medicine, 2018
Lack of association between the P413L variant of chromogranin B and ALS risk or age at onset: a meta-analysis.
Yang X et al.
Amyotrophic Lateral Sclerosis & Frontotemporal Degeneration, 2018
Sex-dependent effects of chromogranin B P413L allelic variant as disease modifier in amyotrophic lateral sclerosis.
Ohta Y et al.
Human Molecular Genetics, 2016
Lack of relationship between the P413L chromogranin B variant and a SALS Italian cohort.
Ricci C et al.
Gene, 2015
Where genotype is not predictive of phenotype: towards an understanding of the molecular basis of reduced penetrance in human inherited disease.
Cooper DN et al.
Human Genetics, 2013
Amyotrophic lateral sclerosis: Problems and prospects.
Sreedharan J et al.
Annals of Neurology, 2013
Hereditary motor neuron disease in a large Norwegian family with a "H46R" substitution in the superoxide dismutase 1 gene.
Østern R et al.
Neuromuscular Disorders : Nmd, 2012
Recurrent G41S mutation in Cu/Zn superoxide dismutase gene (SOD1) causing familial amyotrophic lateral sclerosis in a large Polish family.
Berdyński M et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2012
A functional variant in ZNF512B is associated with susceptibility to amyotrophic lateral sclerosis in Japanese.
Iida A et al.
Human Molecular Genetics, 2011
Permanent diabetes during the first year of life: multiple gene screening in 54 patients.
Russo L et al.
Diabetologia, 2011
The P413L chromogranin B variation in French patients with sporadic amyotrophic lateral sclerosis.
Blasco H et al.
Amyotrophic Lateral Sclerosis : Official Publication of the World Federation of Neurology Research Group on Motor Neuron Diseases, 2011
Neuroinflammation in amyotrophic lateral sclerosis: role of glial activation in motor neuron disease.
Philips T et al.
The Lancet. Neurology, 2011
The neurobiology of amyotrophic lateral sclerosis.
Bento-Abreu A et al.
The European Journal of Neuroscience, 2010
Chromogranin B P413L variant as risk factor and modifier of disease onset for amyotrophic lateral sclerosis.
Gros-Louis F et al.
Proceedings of the National Academy of Sciences of the United States of America, 2009
Association between chromogranin b gene polymorphisms and schizophrenia in the Japanese population.
Iijima Y et al.
Biological Psychiatry, 2004